Health Canada grants Interim Order authorization for casirivimab and imdevimab for the treatment of mild to moderate COVID-19
/CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that Health Canada has issued an Interim Order authorization for casirivimab and imdevimab...
Source: newswire.ca